Connor, Clark & Lunn Investment Management Ltd.
Position in AMLX — Amylyx Pharmaceuticals, Inc.
CIK 1596800
VANCOUVER, A1
Position in AMLX
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$12,069,717
-$58,856 QoQ
Shares Held
868,325
-13.5% QoQ
Ownership
0.781%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
11 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in AMLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Connor, Clark & Lunn Investment Management Ltd. holds $123,963,967 across 16 Drug Manufacturers - Specialty & Generic names. AMLX ranks #5 (9.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
649,629 | $31,279,636 | |
| 2 | ZTS |
Zoetis Inc.
|
187,329 | $22,144,161 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
153,755 | $20,255,683 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
471,891 | $14,213,356 | |
| 5 | AMLX |
Amylyx Pharmaceuticals, Inc.
This page
|
868,325 | $12,069,717 | |
| 6 | IRWD |
Ironwood Pharmaceuticals Inc
|
1,835,424 | $6,442,338 | |
| 7 | EBS |
Emergent BioSolutions Inc.
|
648,377 | $5,381,529 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
|
382,976 | $5,304,217 |
All Filings in AMLX
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,069,717 | 868,325 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $12,128,573 | 1,004,021 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $15,044,238 | 1,107,008 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $7,400,248 | 1,154,485 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $4,246,906 | 1,199,691 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $4,775,474 | 1,263,353 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $2,853,613 | 880,745 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $1,181,661 | 621,927 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,495,793 | 526,688 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $3,777,240 | 256,606 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $2,278,771 | 124,455 | Shares | Sole | 2023-11-13 | |
| No filing history on record for this holder in this stock. | ||||||